Development
SOPHiA GENETICS SA
SOPH
$3.13
$0.082.62%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 17.05M | 16.30M | 15.05M | 13.97M | 13.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.05M | 16.30M | 15.05M | 13.97M | 13.38M |
| Cost of Revenue | 5.15M | 5.03M | 5.01M | 4.27M | 3.75M |
| Gross Profit | 11.90M | 11.27M | 10.05M | 9.69M | 9.63M |
| SG&A Expenses | 21.24M | 19.58M | 21.24M | 19.67M | 18.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -177.00K | -746.00K | -41.00K | -19.00K | -325.00K |
| Total Operating Expenses | 35.97M | 32.85M | 35.10M | 33.25M | 28.40M |
| Operating Income | -18.92M | -16.54M | -20.05M | -19.29M | -15.01M |
| Income Before Tax | -24.05M | -13.53M | -21.32M | -19.59M | -14.23M |
| Income Tax Expenses | 8.00K | 299.00K | 73.00K | 107.00K | -258.00K |
| Earnings from Continuing Operations | -24.06M | -13.82M | -21.40M | -19.70M | -13.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.06M | -13.82M | -21.40M | -19.70M | -13.97M |
| EBIT | -18.92M | -16.54M | -20.05M | -19.29M | -15.01M |
| EBITDA | -18.45M | -14.90M | -18.71M | -17.40M | -14.69M |
| EPS Basic | -0.37 | -0.21 | -0.33 | -0.31 | -0.22 |
| Normalized Basic EPS | -0.23 | -0.13 | -0.21 | -0.19 | -0.14 |
| EPS Diluted | -0.37 | -0.21 | -0.33 | -0.31 | -0.22 |
| Normalized Diluted EPS | -0.23 | -0.13 | -0.21 | -0.19 | -0.14 |
| Average Basic Shares Outstanding | 65.03M | 65.07M | 64.50M | 64.24M | 64.22M |
| Average Diluted Shares Outstanding | 65.03M | 65.07M | 64.50M | 64.24M | 64.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |